The process and content of telehealth cancer genetic counselling — ASN Events

The process and content of telehealth cancer genetic counselling (#273)

Bronwyn R Calford 1 , Elvira Zilliacus 1 2 , Bettina Meiser 1 2 3 , Elizabeth Lobb 4 , Allan Spigelman 5 6 , Kathy Tucker 3
  1. Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia
  2. Psychosocial Research Group, Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia
  3. Medical Oncology, Prince of Wales Hospital, Sydney, NSW, Australia
  4. Calvary Health Care, Kogarah, NSW, Australia
  5. Hunter Family Cancer Service, Hunter New England Health, Newcastle, NSW, Australia
  6. St Vincents Clinical School, Sydney University, Sydney, NSW, Australia

Background:  New modes of service delivery have been implemented to meet the increasing demand for genetic services. In Australia genetic counseling for hereditary breast/ovarian cancer (HBOC) is available via videoconferencing for rural and outreach patients.  This study aimed to identify practitioner behaviors in telegenetics consultations that influenced patient outcomes. Methods: Seventy women attending telegenetics consultations, who were at moderate or high risk of HBOC, completed self report questionnaires pre-consultation and 1-month post consultation.  The telehealth appointments were digitally recorded and consultation content and clinician communication behaviors were analyzed. Results: Women who had more aspects of genetic testing discussed had a significant decrease in perceived personal control (β=-0.4, 95%CI=-0·798--0·015, p=0·04).  Women who had more aspects of breast cancer prevention discussed had a significant increase in breast cancer specific anxiety (β=3·6, 95%CI=0·583-6·62 p=0·02).  Support person presence, genetic counselor input, technical distractions, use of behaviors that encourage patient involvement, use of behaviors that facilitate understanding, partnership-building behaviors, supportive/counseling behaviors, and discussing screening, risk-reducing surgery, and genetics education, were not significantly associated with patient outcomes.  Conclusion: This study showed that while telegenetics improves patient outcomes, clinicians may need to reframe discussion of genetic testing in a way that empowers women and promotes a sense of personal control.